Join the 'Psoriasis' group to help and get support from people like you.

Psoriasis Blog

Related terms: Palmo-plantar Psoriasis, Erythrodermic Psoriasis, Guttate Psoriasis, Inverse Psoriasis, Psoriasis vulgaris, Pustular Psoriasis

Steroids Often Prescribed for Psoriasis, Countering Guidelines

Posted 28 Feb 2014 by Drugs.com

FRIDAY, Feb. 28, 2014 – Although corticosteroid pills are not recommended for the management of psoriasis, new research reveals these drugs are commonly prescribed by dermatologists treating this chronic skin condition. Corticosteroids, including prednisone, dexamethasone and methylprednisolone, were the second most commonly prescribed systemic medications (not preparations applied to the skin) for psoriasis, according to a study from Wake Forest Baptist Medical Center. "Expert guidelines discourage their use for psoriasis due to concerns about causing flares of generalized pustular psoriasis, but there are no randomized controlled trials of systemic corticosteroids in psoriasis to look at these issues," study co-author Scott Davis, assistant director of the Center for Dermatology Research at Wake Forest Baptist Medical Center, said in a Wake Forest news release. In conducting the ... Read more

Related support groups: Prednisone, Psoriasis, Methylprednisolone, Medrol, Dexamethasone, Decadron, Solu-Medrol, Depo-Medrol, Medrol Dosepak, Deltasone, Sterapred, MethylPREDNISolone Dose Pack, Decadron Tablets, Adrenocot, Sterapred DS, A-methapred, Liquid Pred, Rayos, Adrenocot LA, Decaject

Study Sees Link Between Psoriasis, Kidney Problems

Posted 16 Oct 2013 by Drugs.com

TUESDAY, Oct. 15 – People with moderate to severe psoriasis are at increased risk for chronic kidney disease and need to be closely monitored for kidney problems, a large new study suggests. Researchers in Philadelphia analyzed data from nearly 144,000 people, aged 19 to 90, with psoriasis, and a comparison (control) group of nearly 690,000 adults without the condition. During seven years of follow-up, people with psoriasis were more likely to develop chronic kidney disease than those in the control group. Those with severe psoriasis had a nearly two-fold higher risk of developing kidney disease and a more than fourfold higher risk of developing kidney failure requiring dialysis, according to a journal news release Further investigation that focused on the amount of skin area affected by psoriasis showed that people with moderate to severe psoriasis were at greater risk of developing ... Read more

Related support groups: Psoriasis, Chronic Kidney Disease

Otrexup (Methotrexate) Injection Approved By FDA

Posted 15 Oct 2013 by Drugs.com

EWING, N.J., October 14, 2013 — Antares Pharma, Inc. today announced the approval of Otrexup (methotrexate) injection by the U.S. Food and Drug Administration (FDA). Otrexup is the first FDA approved subcutaneous (SC) methotrexate (MTX) for once weekly self-administration with an easy-to-use, single dose, disposable auto injector. Otrexup is indicated for adults with severe active rheumatoid arthritis (RA) who have had an insufficient therapeutic response to or are intolerant of an adequate trial of first line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs), or children with active polyarticular juvenile idiopathic arthritis (pJIA). The FDA also approved adult use of Otrexup for symptomatic control of severe recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy. In 2012, approximately six million prescriptions were w ... Read more

Related support groups: Rheumatoid Arthritis, Methotrexate, Psoriasis, Juvenile Rheumatoid Arthritis, Juvenile Idiopathic Arthritis

Skin Care Tips for Psoriasis Patients

Posted 23 Aug 2013 by Drugs.com

FRIDAY, Aug. 23 – Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking and bleeding, an expert says. "It's extremely important for people with psoriasis to protect their skin from excessive sun," Dr. Stephen Stone, a professor of dermatology and director of clinical research at Southern Illinois University School of Medicine, said in an American Academy of Dermatology news release. "Being exposed to the sun for too long can worsen existing psoriasis and cause new psoriasis to form." Psoriasis causes red, scaly patches on the skin of the scalp, elbows or other parts of the body. The condition is believed to be caused by an interaction of genes, the immune system and the environment. Along with emphasizing sun protection, Stone offered other tips to ... Read more

Related support groups: Psoriasis

Many Psoriasis Patients Going Without Treatment, Study Finds

Posted 14 Aug 2013 by Drugs.com

WEDNESDAY, Aug. 14 – The autoimmune skin disorder known as psoriasis affects millions of Americans, but a new study suggests it remains woefully undertreated. In 2011, between 30 percent and nearly 50 percent of patients said they had no treatment for their psoriasis, depending on the severity of their disease. One expert unconnected to the study said he wasn't surprised by the findings. "Dermatologists, especially those that specialize in caring for patients with psoriasis, are well aware of the fact that many patients are untreated or undertreated," said Dr. Gary Goldenberg, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai, in New York City. "This is especially concerning for those patients with moderate to severe disease and those with psoriatic arthritis, which affects approximately 30 percent of patients with psoriasis." Psoriasis is an immune ... Read more

Related support groups: Psoriasis

Psoriasis, Other Medical Conditions May Be Linked, Study Says

Posted 7 Aug 2013 by Drugs.com

WEDNESDAY, Aug. 7 – People with the skin disease psoriasis may be at increased risk for other major health problems, according to a new study. The link between psoriasis, which is characterized by irritated, red patches of skin, and other medical conditions has been unclear. In this study, published online Aug. 7 in the journal JAMA Dermatology, researchers analyzed data from more than 9,000 British psoriasis patients, aged 25 to 64. They compared them with more than 90,000 age-matched people without psoriasis. Among the psoriasis patients, the disease was mild in nearly 52 percent, moderate in nearly 36 percent and severe in about 12 percent. The analysis revealed that people with psoriasis had higher rates of chronic lung disease, diabetes, mild liver disease, heart attack, peptic ulcer, peripheral vascular disease, kidney disease and rheumatologic disease. The risk of having these ... Read more

Related support groups: Psoriasis

Weight Loss Might Ease Psoriasis, Study Hints

Posted 29 May 2013 by Drugs.com

WEDNESDAY, May 29 – People with psoriasis who lose weight could experience some relief from the symptoms of their chronic skin disease, according to a small new study. A clinical trial based in Denmark found that obese patients with psoriasis who lost weight through a low-calorie diet experienced a significant improvement in their quality of life, compared to obese psoriasis patients who didn't lose weight. The patients in the weight-loss group reported less stinging and burning, were less likely to be embarrassed by unsightly lesions, and found that their condition affected their everyday life less often, said Dr. Peter Jensen, of the Copenhagen University Hospital Gentofte, and colleagues. "Our results emphasize the importance of weight loss as part of a multimodal treatment approach to effectively treat both the skin condition and its [related medical] conditions in overweight ... Read more

Related support groups: Psoriasis

Salty Diet Might Help Trigger MS, Rheumatoid Arthritis

Posted 6 Mar 2013 by Drugs.com

WEDNESDAY, March 6 – Eating lots of foods loaded with salt may do more than raise your blood pressure: Researchers report that it could also contribute to the development of autoimmune diseases, where the body's immune system mistakenly mounts an attack upon some part of the body. Three new studies suggest salt may be a prime suspect in a wide range of autoimmune diseases, including multiple sclerosis (MS), psoriasis, rheumatoid arthritis and ankylosing spondylitis (arthritis of the spine). A significant increase in the incidence of autoimmune diseases, especially multiple sclerosis and type 1 diabetes, suggests that environmental factors, and not genetics, may explain the trend, the researchers noted. "The diet does affect the autoimmune system in ways that have not been previously recognized," said senior study author Dr. David Hafler, a professor of neurology and immunobiology at ... Read more

Related support groups: Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Ankylosing Spondylitis, Rheumatoid Lung

Kids With Psoriasis More Likely to Be Overweight: Study

Posted 19 Nov 2012 by Drugs.com

MONDAY, Nov. 19 – Children who have the skin condition psoriasis are about twice as likely to be either overweight or obese as kids without the skin problem, according to new research that looked at children from nine countries. When researchers looked at just obesity, they found those with the skin condition were four times as likely to be obese, said Dr. Amy Paller, a professor and chair of dermatology at Northwestern University Feinberg School of Medicine, who led the study. It is published online Nov. 19 in the Archives of Dermatology. U.S. children with severe psoriasis were seven times as likely to be obese as children without the skin condition. "Pediatric psoriasis is a little bit of an orphan," Paller said. "It's very little studied." She decided to take a closer look, especially because much research has shown that adults with psoriasis are often overweight. Experts have ... Read more

Related support groups: Obesity, Psoriasis

Psoriasis Drug May Help People With Crohn's Disease: Study

Posted 17 Oct 2012 by Drugs.com

WEDNESDAY, Oct. 17 – The drug Stelara, used to treat the skin condition psoriasis, may also be effective against Crohn's disease, according to a new study. Researchers from the University of California, San Diego School of Medicine found Stelara (ustekinumab) blocks two proteins known to cause inflammation. Crohn's disease patients with moderate-to-severe cases of the debilitating inflammatory bowel disease experienced improvements after six weeks of treatment, the team noted. One specialist not connected to the study welcomed the results. "This study confirms an earlier study showing that ustekinumab can be an effective therapy," said Dr. Bruce Sands, professor of medicine at the Mount Sinai School of Medicine in New York City. "Given the large unmet need for these individuals with refractory [hard-to-treat] Crohn's disease, these results are a great step forward," he said. Roughly ... Read more

Related support groups: Psoriasis, Crohn's Disease, Stelara, Ustekinumab

Health Tip: Managing With Psoriasis

Posted 18 Sep 2012 by Drugs.com

-- Psoriasis is a chronic skin disease with no cure, but living a healthier lifestyle can help you control symptoms such as itching and flaking. The National Psoriasis Foundation offers these suggestions for healthier living, despite psoriasis: Find healthy ways – such as yoga or meditation – to manage your emotions and stress. Get plenty of daily physical activity. Make gradual changes to your diet to help you eat healthier. Seek help when you need it from friends and family. Read more

Related support groups: Psoriasis

Newer Psoriasis Drugs May Lower Heart Attack Risk for Patients

Posted 20 Aug 2012 by Drugs.com

MONDAY, Aug. 20 – People with psoriasis who take a new class of drugs known as tumor necrosis factor (TNF) inhibitors may be at a lower risk for heart attack than their counterparts who only use topical medications to treat this inflammatory skin condition, a new study shows. And patients taking older systemic medicines and phototherapy may also have a reduced heart attack risk compared to those using topical preparations, the study found. Of 8,845 study participants, about 57 percent were treated with topical therapy only, 19 percent received a TNF inhibitor for at least two months and about 24 percent were treated with other medications or phototherapy. People who were treated with TNF inhibitors had a 50 percent lower risk, and those treated with other psoriasis drugs or phototherapy had a 46 percent lower risk for heart attack, than those who used topical medications alone. The ... Read more

Related support groups: Rheumatoid Arthritis, Methotrexate, Psoriasis, Humira, Enbrel, Remicade, Cyclosporine, Cimzia, Simponi, Soriatane, Infliximab, Neoral, Etanercept, Acitretin, Adalimumab, Gengraf, Golimumab, Trexall, Methotrexate LPF Sodium, Sandimmune

Shingles Vaccine Safe for Those With Autoimmune Diseases: Study

Posted 3 Jul 2012 by Drugs.com

TUESDAY, July 3 – For those suffering from the chronic skin disorder psoriasis and other autoimmune diseases, a new study finds the shingles vaccine appears to be both safe and effective. It had been thought the vaccine might boost the risk of developing shingles in these patients, the researchers explained. "The findings are reassuring for a very specific group of patients," said Dr. Bruce Hirsch, an attending physician in infectious diseases at North Shore University Hospital in Manhasset, N.Y., who was not involved in the study. "Patients who have weak immune systems are vulnerable to getting shingles and the shingles vaccine is a live vaccine," he added. The study looked at patients with rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis (an inflammation of the spine), or inflammatory bowel disease. The risk is that patients with these conditions are ... Read more

Related support groups: Psoriasis, Autoimmune Disorders, Zostavax, Zoster Vaccine Live

Could Psoriasis Increase Odds for Type 2 Diabetes?

Posted 18 Jun 2012 by Drugs.com

MONDAY, June 18 – People suffering from the autoimmune skin disorder known as psoriasis may face an increased risk of developing type 2 diabetes, a new study suggests. "People with psoriasis are at increased risk of developing diabetes that is independent of traditional risk factors like being obese," said lead researcher Dr. Joel Gelfand, associate professor of dermatology at the University of Pennsylvania in Philadelphia. The risk is highest in those with the most severe psoriasis, and these patients should be screened for diabetes, he said. The reasons for this risk may be genetic, or psoriasis may cause increased insulin resistance, Gelfand said. He also noted that obesity is a risk factor for psoriasis as well as diabetes. People who develop psoriasis should try to maintain a healthy weight to help prevent diabetes, he said. The report was published in the June 18 online edition ... Read more

Related support groups: Diabetes, Type 2, Psoriasis

Vigorous Exercise Might Keep Psoriasis at Bay

Posted 21 May 2012 by Drugs.com

MONDAY, May 21 – Women who exercise vigorously may be reducing their risk of psoriasis, Harvard University researchers report. Psoriasis is an immune disorder that causes inflammation and scaly patches on the skin. Vigorous activity for up to three hours a week can potentially reduce the risk by 25 percent to 30 percent, the researchers said. "Exercise is a modifiable risk factor. Here is another reason to change lifestyle and exercise," said lead researcher Dr. Abrar Qureshi, vice chairman of the department of dermatology at Brigham and Women's Hospital, in Boston. "Most interesting was our finding that intensity of exercise was linked to psoriasis risk, where less vigorous physical activity such as walking was not associated with a lower risk for new-onset psoriasis," he said. The report was published in the May 21 online edition of the Archives of Dermatology. For the study, ... Read more

Related support groups: Psoriasis

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Plaque Psoriasis, Psoriatic Arthropathy, Dermatological Disorders

Related Drug Support Groups

prednisone, methotrexate, Humira, Remicade, methylprednisolone, triamcinolone, dexamethasone, clobetasol, fluocinonide, view more... Therapeutic, Clobex, Kenalog, cyclosporine, desonide, Stelara, desoximetasone, hydroxyurea, Elocon, Topicort, Dovonex, Soriatane, Lidex, Tazorac, Halog, Olux, infliximab, Cordran, Cloderm, Cordran Tape, Acthar, Neoral, Kenalog-10, Acth, Locoid, etanercept, Kenalog-40, feverfew, Cortizone-10, coal tar, Eczema Cream, Vanos, Temovate, Olux-E, acitretin, Cortaid, Analpram-HC, Acthar Gel, HP, Deltasone, adalimumab, methoxsalen, ustekinumab, anthralin, halobetasol, halcinonide, Ultravate, Dermovate, tazarotene, Linotar, Proctofoam HC, Verdeso, Aristocort A, Sterapred, Locoid Lipocream, Taclonex, calcipotriene, resorcinol, Linotar Gel 2, Gengraf, Cyclocort, alclometasone, betamethasone/calcipotriene, Corticaine, Zone-A, Aquanil HC, Hemorrhoidal HC, Desonate, Hycort, Dermatop, X-Seb T Plus, Triderm, Oxsoralen-Ultra, Anti-Dandruff, Liquid Pred, Anucort-HC, Doak Tar Oil, DHS Tar Shampoo, MG 217 Psoriasis, Cortaid Maximum Strength, Neutrogena T/Derm, Soriatane CK, Sterapred DS, Cortane, Aristocort for Injection, Dermarest Dricort, corticotropin, Trianex, Hytone, Doak Tar, Topicort LP, Fototar, Linotar Gel 3, DesOwen, Methotrexate LPF Sodium, Doak Oil Forte, Halog-E, Amevive, Pramosone, Vectical, Dritho-Scalp, Aclovate, Trexall, Taclonex Scalp, Aristospan, Psoriatec, Nutracort, hydrocortisone/pramoxine, diflorasone, Anurx-HC, Keratol HC, Cortaid with Aloe, Acticort 100, Aloe Cort, Delcort, Gly-Cort, Hi-Cor, Dermolate, Ultralytic, Corticreme, Dermol HC, Caldecort, Lacticare-HC, Anumed-HC, Hemril-HC Uniserts, Otrexup, Hydrocort cream, Texacort, Rectasol-HC, Procto-Kit 1%, Procto-Kit 2.5%, Proctosol-HC, Anuprep-HC, Aeroseb-HC, Ala-Cort, Ala-Scalp HP, Dermacort, Cetacort, Cort-Dome High Potency, Proctocort, Zithranol, Penecort, Westcort, Cotacort, Anutone-HC, Anuzone HC, Psoriasin, Ultralytic 2, Ultravate PAC, Anthrascalp, Dermagesic, Temovate E, OraMagic Rx, Itch-X Lotion, Procto-Pak 1%, Carb-O-Lac5, Z-Xtra, Olux/Olux-E Kit, Resinol, Scytera, Zithranol-RR, Cormax Scalp, Ala-Scalp, Halonate, Sorilux, Analpram E, Hydrocortisone 1% In Absorbase, Anthraforte, Fluocinonide-E, Scalacort, HC Pram, Calcitrene, Gynecort Maximum Strength, NuZon, Beta HC, Scalp-Cort, Ivocort, Pandel, Proctocream-HC, Instacort 10, Genasone/Aloe, Rederm, Recort Plus, Sarnol-HC, Scalp-Aid, Cort-Dome, Nupercainal HC 1%, Dermarest Plus Anti-Itch, Proctosert HC, Proctozone HC, U-Cort, Cortaid Intensive Therapy, Encort, Proctozone-H, Hemril-30, Cortizone for Kids, Cortizone-5, Neutrogena T-Scalp, Dermtex HC, Cortizone-10 Plus, Nogenic HC, Zone-A Forte, Triam-A, Triamonide 40, Kenaject-40, Cort-K, Triamcot, Tramacort-D, Tristoject, Triam-Forte, Orasone, Meticorten, Prednicen-M, Prednicot, TAC 3, Trilog, Trilone, Temovate Emollient, A-Fil, Cormax, Embeline E, Clobevate, Micanol, Drithocreme, Clinacort, U-Tri-Lone, Clinalog, Ken-Jec 40, Anthra-Derm, Folex PFS, Tarsum, benzocaine/pyrilamine/zinc oxide, prednicarbate, ammonium lactate/halobetasol, Embeline, MG217 Medicated Tar, flurandrenolide, efalizumab, amcinonide, alefacept, ammonium lactate/urea, clocortolone, coal tar/salicylic acid, Medotar, Ionil T, ProctoCare-HC, Epifoam, Instacort, Scalpicin, 8-MOP, Cordran SP, Lidex-E, LoKara, Tridesilon, Apexicon, Maxiflor, Raptiva, Delonide, Florone, Doctar, Polytar, Cutar, Elta Tar, Reme-T, Psorigel, Tegrin Medicated Soap, Betatar Gel, Balnetar, Theraplex T, Oxipor VHC, Pentrax Gold, Exorex, Polytar Mild, Apha Keri Tar Gel, Orion Coal Tar, Pinetarsol Tar, R A Acne, Dovobet, Apha Keri Tar, Coal Tar Strong, Clinitar, Psoriderm, Alphosyl, Alphosyl 2 in 1, Carbo-Dome, Estar, Pentrax, Aricin, Triacet, Aristocort R, Delta-Tritex, Flutex, Fluex, Dermacin, Florone E, Psorcon, Psorcon E, ApexiCon E, Licon, Rx Triamcinolone, Cinalog, Zeprime Tar Emulsion, G-TAR, Ionil T Plus, Neutrogena T/Gel, Tegrin Medicated, Zetar, HC Pramoxine, Enzone, Cinolar, Rectocort HC, Novacort, Hydropram, Utralytic